Literature DB >> 29274663

Long Noncoding RNA in Cancer: Wiring Signaling Circuitry.

Chunru Lin1, Liuqing Yang2.   

Abstract

Long noncoding RNAs (lncRNAs), which are encoded by a vast less explored region of the human genome, may hold missing drivers of cancer and have gained attention recently as a potentially crucial layer of cancer cell regulation. lncRNAs are aberrantly expressed in a broad spectrum of cancers, and they play key roles in promoting and maintaining tumor initiation and progression, demonstrating their clinical potential as biomarkers and therapeutic targets. Recent discoveries have revealed that lncRNAs act as key signal transduction mediators in cancer signaling pathways by interacting with proteins, RNA, and lipids. Here, we review the mechanisms by which lncRNAs regulate cellular responses to extracellular signals and discuss their clinical potential as diagnostic indicators, stratification markers, and therapeutic targets of combinatorial treatments.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antisense oligonucleotides; biomarker; cancer; effector; kinase; ligand; locked nucleic acid; long noncoding RNAs; metastasis; nanoparticle-delivered siRNAs; receptor; signal transducer; signaling pathway

Mesh:

Substances:

Year:  2017        PMID: 29274663      PMCID: PMC5869122          DOI: 10.1016/j.tcb.2017.11.008

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  136 in total

Review 1.  Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.

Authors:  Richard S Geary; Daniel Norris; Rosie Yu; C Frank Bennett
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

2.  The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia.

Authors:  J Dürig; U Dührsen; L Klein-Hitpass; J Worm; J B Rode Hansen; H Ørum; M Wissenbach
Journal:  Leukemia       Date:  2011-03-01       Impact factor: 11.528

3.  lncRNA directs cooperative epigenetic regulation downstream of chemokine signals.

Authors:  Zhen Xing; Aifu Lin; Chunlai Li; Ke Liang; Shouyu Wang; Yang Liu; Peter K Park; Li Qin; Yongkun Wei; David H Hawke; Mien-Chie Hung; Chunru Lin; Liuqing Yang
Journal:  Cell       Date:  2014-11-13       Impact factor: 41.582

4.  A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.

Authors:  Manuel Beltran; Isabel Puig; Cristina Peña; José Miguel García; Ana Belén Alvarez; Raúl Peña; Félix Bonilla; Antonio García de Herreros
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

5.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

6.  AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.

Authors:  David Hong; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Morvarid Mohseni; Deborah Lawson; Corinne Reimer; David C Blakey; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

7.  The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.

Authors:  Marissa Iden; Samantha Fye; Keguo Li; Tamjid Chowdhury; Ramani Ramchandran; Janet S Rader
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

8.  The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells.

Authors:  Mark R Pickard; Gwyn T Williams
Journal:  Oncotarget       Date:  2016-03-01

9.  Association between SNPs in Long Non-coding RNAs and the Risk of Female Breast Cancer in a Chinese Population.

Authors:  Tao Xu; Xiu-Xiu Hu; Xiang-Xiang Liu; Han-Jin Wang; Kang Lin; Yu-Qin Pan; Hui-Ling Sun; Hong-Xin Peng; Xiao-Xiang Chen; Shu-Kui Wang; Bang-Shun He
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

10.  Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population.

Authors:  Zongjiang Xia; Rui Yan; Fujiao Duan; Chunhua Song; Peng Wang; Kaijuan Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  192 in total

1.  Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers.

Authors:  Yue Gao; Peng Wang; Yanxia Wang; Xueyan Ma; Hui Zhi; Dianshuang Zhou; Xin Li; Ying Fang; Weitao Shen; Yingqi Xu; Shipeng Shang; Lihua Wang; Li Wang; Shangwei Ning; Xia Li
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

2.  Comparative analysis of long noncoding RNAs in long-lived mammals provides insights into natural cancer-resistance.

Authors:  Jian-Jun Jiang; Qing-Peng Kong
Journal:  RNA Biol       Date:  2020-07-17       Impact factor: 4.652

Review 3.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

4.  Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis.

Authors:  Xuan Zhu; Xing Niu; Chunlin Ge
Journal:  Cancer Biol Ther       Date:  2019-02-11       Impact factor: 4.742

Review 5.  The development and controversy of competitive endogenous RNA hypothesis in non-coding genes.

Authors:  Weimin Lin; Hongcheng Liu; Yonghang Tang; Yuchen Wei; Wei Wei; Lifan Zhang; Jie Chen
Journal:  Mol Cell Biochem       Date:  2020-09-25       Impact factor: 3.396

6.  Long noncoding RNA LRRC75A-AS1 inhibits cell proliferation and migration in colorectal carcinoma.

Authors:  Jianxiong Chen; Jiawen Lan; Zhiwei Ye; Shiyu Duan; Yukun Hu; Ying Zou; Jun Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-10

7.  MEG3 can affect the proliferation and migration of colorectal cancer cells through regulating miR-376/PRKD1 axis.

Authors:  Xiangbin Wu; Jinlei Li; Yuehan Ren; Zhigui Zuo; Shichang Ni; Jianhui Cai
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

8.  Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.

Authors:  Rui Wang; Bin Zheng; Hongyan Liu; Xiuxian Wan
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

Review 9.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

Review 10.  Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?

Authors:  Nieves Martinez Chanza; Abhishek Tripathi; Lauren C Harshman
Journal:  Curr Treat Options Oncol       Date:  2019-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.